Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)
Sponsor: Definium Therapeutics US, Inc.
Summary
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Emerge
Official title: A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Major Depressive Disorder - Emerge
Key Details
Gender
All
Age Range
18 Years - 74 Years
Study Type
INTERVENTIONAL
Enrollment
149
Start Date
2025-04-14
Completion Date
2027-02
Last Updated
2026-08-28
Healthy Volunteers
No
Conditions
Interventions
Placebo
A substance that is designed to have no therapeutic value
DT120
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A)
Locations (22)
Preferred Research Partners, Inc
Little Rock, Arkansas, United States
Kadima Neuropsychiatry Institute
La Jolla, California, United States
Psychedelic Science Institute
Santa Monica, California, United States
Mountain View Clinical Research, Inc
Denver, Colorado, United States
CNS, LLC (Jacksonville)
Jacksonville, Florida, United States
CNS, LLC (Orlando)
Orlando, Florida, United States
Charter Research
Orlando, Florida, United States
Uptown Research Institute (URI), LLC
Chicago, Illinois, United States
Sheppard Pratt
Baltimore, Maryland, United States
Adams Clinical Boston
Boston, Massachusetts, United States
Adams Clinical
Watertown, Massachusetts, United States
University of Missouri
Columbia, Missouri, United States
Cenexel HRI
Berlin, New Jersey, United States
Adams Clinical Harlem
New York, New York, United States
Columbia - New York State Psychiatric Institute
New York, New York, United States
Neuro-Behavioral Clinical Research
Canton, Ohio, United States
University of Cincinnati
Cincinnati, Ohio, United States
Adams Clinical Philadelphia
Philadelphia, Pennsylvania, United States
CNS, LLC (Memphis)
Memphis, Tennessee, United States
Austin Clinical Trial Partners
Austin, Texas, United States
Cedar Clinical Research
Murray, Utah, United States
Memory Clinic, Inc
Bennington, Vermont, United States